Revenue: The sum of all revenue fields included for a company's operating activities.
Evofem Biosciences, Inc. (EVFM) had Revenue of $2.63M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
|
Revenue |
$2.63M |
$-11.14M |
|
$0.51M |
|
$2.12M |
|
$5.12M |
|
$-2.49M |
|
$-8.55M |
|
$-11.04M |
|
$-11.04M |
|
$-11.04M |
|
$-11.04M |
|
$-11.04M |
|
$-11.04M |
|
$-2.49M |
|
$-2.44M |
|
137.34M |
|
137.34M |
|
$-0.08 |
|
$-0.08 |
|
| Balance Sheet Financials | |
$6.08M |
|
$0.41M |
|
$1.44M |
|
$7.52M |
|
$88.61M |
|
-- |
|
$1.40M |
|
$90.01M |
|
$-87.52M |
|
$-83.36M |
|
$-82.49M |
|
132.53M |
|
| Cash Flow Statement Financials | |
$-0.84M |
|
$-0.00M |
|
$0.55M |
|
$0.58M |
|
$0.28M |
|
$-0.29M |
|
$0.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.07 |
|
-- |
|
-- |
|
-- |
|
-0.66 |
|
80.59% |
|
-94.53% |
|
-94.53% |
|
-- |
|
-419.14% |
|
-423.24% |
|
$-0.84M |
|
-- |
|
-- |
|
-- |
|
0.35 |
|
0.24 |
|
1.05 |
|
85.35 |
|
12.61% |
|
13.24% |
|
-146.72% |
|
13.38% |
|
$-0.62 |
|
$-0.01 |
|
$-0.01 |
|